Cystic fibrosis is an autosomal recessive disorder which affects one in 2500 live births. It is a multisystem disease and has a variety of presentations. The major clinical features affect the gastrointestinal and respiratory tracts. Severe respiratory disease, diabetes and gastroesophageal reflux are common features of concern to anaesthetists. Improved care of young patients has allowed many to survive into adulthood. Lung transplantation has significantly improved the outlook for many patients. At Alfred Hospital, 74 patients with cystic fibrosis underwent 149 procedures from January 1978 to January 1994, with a mortality of 0.6% (95 % Cl 0.4 %-0.8%). This retrospective cohort study describes the anaesthetic management and perioperative care of these patients. Most of the anaesthetics were for procedures related to cystic fibrosis but 12% were for unrelated conditions. Cystic fibrosis related procedures include diagnostic, venous access, enteral feeding procedures, treatment of complications of cystic fibrosis and lung transplantation. Despite extremely poor respiratory function, these patients can be managed with acceptably low postoperative mortality (1%). Pre-and postoperative care must be directed towards optimal clearance of viscous respiratory secretions. Procedures need to be planned so that optimal care can be given by each member of the team caring for cystic fibrosis patients.
Cystic Fibrosis (CF) is an autosomal recessive disorder. The frequency of the carrier state is one in twenty-five of the population making it the most common genetic disorder of Caucasians. It affects one in 2500 live births l in this population. Improvements in the management of paediatric patients with CF have allowed a substantial number to survive into adult life. The major factors which have improved survival are better sputum clearance techniques, antibiotic therapy and nutrition. Earlier reviews of the management of anaesthesia for CF patients were limited to the paediatric group and described a poor prognosis 2 • J At that time, few patients survived into adulthood. A review in 1985 4 included patients up to 29 years of age with only 10070 of the operations on patients aged over 20 years. In 1990 the mean survival was 28 years and it has been calculated that by 1996, half of the CF population will be aged over 18 yearsl. Lung transplantation, increased life expectancy and the quest for better quality of life have increased the number of anaesthetics given to these patients. CF is therefore of increasing importance to anaesthetists. This review reports current anaesthetic management of adults with CF and contrasts this with previously reported paediatric series.
METHOD
With Institutional Ethics Committee approval, medical records of CF patients attending Alfred Hospital, Melbourne, were retrospectively reviewed to find the number of procedures for which anaesthesia was required and the anaesthetic given. For each procedure, the anaesthetic technique and any events in the recovery room and the medical and nursing notes of the post anaesthetic period were recorded. The records were collected until January 1994. General anaesthesia was defined as administration of an intravenous induction agent, muscle relaxant or volatile anaesthetic drug. The vital capacity (VC) and forced expiratory volume in one second (FEV I), measured and predicted were also recorded for each patient who had lung function tests within one month prior to anaesthesia. Procedures and events which followed transplantation are excluded from consideration because many of them related to general care of transplant patients rather than to CF. Data is presented as mean (SD, or 95% confidence interval).
RESULTS
Records of 165 patients (98 males and 67 females) were reviewed. There were 144 anaesthetics for 149 procedures performed on 74 patients. Of the 74 patients there were 49 male and 25 female. The males had a total of 94 procedures and the female 55 procedures. The mean age was 23.2 (5.5 SD) years with a range from 16 to 53 years. Eleven procedures were on patients older than 30 years. One patient required 10 procedures (oesophageal dilatation for stricture secondary to oesophageal reflux). The number of procedures per patient is shown in Table 1 . Procedures can be classified as diagnostic, enteral nutrition, venous access, treatment of complications of CF, transplant, and a miscellaneous group. The list of procedures and their distribution within these categories is shown in Table 2 . The range of anaesthetic technique, airway  management and drugs are detailed in Tables 3, 4 , 5 and 6. Of 51 local/regional anaesthetics, 33 were combined with general anaesthesia. Sedative premedication was given before 39 (270/0) of the 143 anaesthetics. There were 98 general anaesthetics and 31 (31%) were managed with spontaneous ventilation. There were 34 (23%) local or regional anaesthetics of which almost half supplemented general anaesthesia. Of the general anaesthetics, 58 (60%) included administration of nondepolarizing muscle relaxants. There were 19 transplant patients returned to the intensive care unit ventilated. Two other patients were electively admitted to intensive care for management but neither of these was ventilated. Of the other 39 patients, 21 had the muscle relaxant reversed. The remaining 18 patients were considered by the anaesthetist to have recovered spontaneously and were extubated without reversal. There was only one postoperative death in the nontransplant group. This patient developed respiratory failure following laparoscopic cholecystectomy and died from respiratory failure ten days later (mortality =0.60/0, 95% Cl 0.4%-0.8%). The reported problems (n=14), excluding transplanted patients, are listed in Table 7 . Lung function tests performed prior to anaesthesia were available from the records of 58 patients. The measure of respiratory function varied widely. A few patients had near-normal lung function: most were severely impaired. The measured volumes have been expressed as ratios of predicted volumes to describe the character of the lung function abnormalities common to CF patients. The results are shown in Table 8 . The age distribution of the patients reflects improved survival of CF patients and the referral pattern to the Alfred Hospital which is the State Adult CF Centre. The categories and the distribution of procedures differ markedly from previously reported paediatric series 2 • 3 and demonstrate major changes in the management of CF. Lamberty and Rubin in 1985 described three main categories of CF related procedures: surgery for meconium ileus and related procedures, nasal polypectomy and "terminal operations". In their paper more than half the operations were ENT procedures (polypectomy, antrostomy, tonsillectomy, myringotomy). One third were "terminal operations" which included "pulmonary, central venous access and enteral feeding procedures".
ANAESTHETIC TECHNIQUE
The current situation in adults, only nine years later, is very different. Some of the procedures classified in 1985 as "terminal" are now done to improve patient's condition so they can be considered for transplantation. In our series, nutritional, venous access and transplant surgery account for more than half of the procedures. This reflects a more aggressive approach and the improved outlook for patients with CF. Another difference is that patients now survive longer and have time to develop a greater range of conditions unrelated to CF.
The molecular basis of the disease is an abnormality which has been mapped to a single locus on the long arm of the 7th chromosomes. 7 • In the most common abnormality which accounts for over 70070 of CF chromosomes, the deletion of three base pairs eliminates a phenylalanine from the resultant protein.
There are over 230 other alleles of the CF gene: all of these are much less common 8
•
The abnormal protein produced is Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). The presence of CFTR in the cell membrane permits water to cross the apical membrane of epithelium with chloride ions so that secretions produced have a lower water content than normal. There is also increased sodium readsorption from respiratory epithelium. The abnormal chloride channel function is present in sweat glands as well as in the respiratory epithelium 9 ,1O Decreased water content in periciliary fluid makes mucus more viscous and slows mucociliary clearance. There may also be intracellular and surface glycoprotein abnormalities which have a role of pathogenesis.
Even within the same genotype, the disease varies in its expression in different organ systems ll • It has a variety of presentations from the neonatal period to adult life. Diagnosis is based on clinical features consistent with CF as well as two sweat tests with chloride concentration greater than 60 mmol/p2. An alternative method of confirming diagnosis is demonstration of homozygous CF genes on the 7th chromosome l • The most common cause of premature death in CF patients is respiratory failure and prevention of respiratory failure is a major focus of the perioperative care of these patients. The development of respiratory disease results from colonization of the viscous secretions and then chronic infection with a range of microorganisms. Initially the lower respiratory tract is colonized with Haemophilus influenzae. This is later replaced by Stahylococcus aureus and then Pseudomonas aeruginosa or Pseudomonas cepacia l3 • The presence of bacteria results in release of proteases from neutrophils and pulmonary macrophages. Proteolysis results in loss of lung parenchyma, destruction of supporting tissue and development of airway obstruction l4 • Airway hyperreactivity is common and may be contributed to by the immune response to the prolonged and varied antigenic stimuli l5 , 16 The main components of treatment are physical treatments and exercise to optimize sputum clearance and aggressive antibiotic treatment of infective exacerbations. Other therapies include mucolytics and ipratropium. Steroids are used for patients with airway hyperreactivity. Sympathomimetics are used regularly and may be increased during exacerbations 17 • In maintenance therapy, the place of other bronchodilators and anticholinergics is controversial.
Lung Function
The mean FEV\ of 57% demonstrates significant airway obstruction. Nearly half of the patients had an FEV\ which was half of the predicted "normal" value for their size. Severely affected patients have an FEV\ which approaches their tidal volume. At this stage of disease, dyspnoea at rest limits cooperation with spirometry.
Complications
Whenever possible, these patients are managed in the respiratory ward rather than a surgical ward. This Anaesthesia and Intensive Care, Vol. 23, No. 3, June, 1995 policy is consistent with the emphasis on respiratory care. Few complications were recorded. This is not to suggest that there are no problems but that the staff who care for the patients are familiar with them and their disease. Prolonged coughing and low oxygen saturations which would usually be cause for concern may have been accepted as "normal". The outstanding feature was the frequency with which comments were made in the notes about difficulty in providing adequate analgesia even after relatively small procedures. Even after insertion of Portacath® or gastrostomy tubes, most patients required opioids prior to physiotherapy.
Cystic Fibrosis-Respiratory Disease
Serious respiratory complications include pneumothorax, empyema and haemoptysis from erosion of hypertrophic bronchial arteries which supply the chronically infected lung. The place of pleurodesis in the management of recurrent pneumothorax has been reduced by the development of endoscopic techniques. The emergency of lung transplantation as a major therapeutic advance for these patients has provided a disincentive to obliterate the pleural cavity because it increases the difficulty of subsequent lung transplantation. Haemoptysis from erosion of bronchial arteries may be treated by embolization of bronchial arteries by experienced interventional radiologists. The three bronchial artery embolization procedures listed were performed by radiologists under local anaesthesia while the patients received monitored care from an anaesthetist. They account for only 100/0 of all embolizations performed on CF patients.
Non-Respiratory Manifestations of CF
Chronic sinusitis, exocrine pancreatic insufficiency with malabsorption, and diabetes are additional features. Approximately 750/0 of CF patients have glucose intolerance and 15% develop diabetes. The pattern of diabetes in CF differs from the usual type I and type 11 diabetes and is unique to CF. It has the pattern of intermittent hyperglycaemia, not associated with ketosis, which responds to insulin 1s • Provided excessive glucose administration is avoided, complications of the diabetes are most unlikely.
Gastrointestinal manifestations of the disease include meconium ileus (which accounts for presentation at birth in 12% of CF patients), gastroesophageal reflux (12% prevalence in CF adults), recurrent constipation (meconium ileus equivalent in adults) and rectal prolapse l9
• Each of these conditions may require surgical intervention.
Hepatobiliary disease is common and includes fatty liver (401170), focal cirrhosis (251170) and cholelithiasis (121170)20. Exocrine pancreatic dysfunction requires oral enzyme supplementation to maintain absorption of fats and fat soluble vitamins.
An almost universal feature which has contributions from most of the above features is a degree of malnutrition. As respiratory disease becomes severe, the metabolic rate increases and most patients fall below ideal body weight. The issue of malnutrition is of imporance in the perioperative period because of its implications for wound healing and immune competence, and because a significant number of procedures on these patients are to permit nutritional supplementation.
ANAESTHETIC MANAGEMENT OF CF PATIENTS Approach to the CF Patient
CF patients who have survived into adulthood may do so because they have only mild pulmonary disease but more often because they have made great efforts to participate in treatment. These patients make their own assessment as to when additional treatment, including hospital admission, is required. They have extensive knowledge of the disease, its treatment, and its complications and need to be involved in decisionmaking whenever possible.
Assessment and Planning
An important issue is the timing of the procedure. Respiratory function runs a course of exacerbations and progressive deterioration but there are times of "optimal" function when sputum production is at a minimum. Elective procedures should only be performed at these times.
Prior to any procedure likely to impair sputum clearance, antibiotic sensitivities of colonizing organisms should be tested to permit rational selection of antibiotics. The time of day should be carefully considered. Sputum clearance should continue until the patient comes to the operating room. Some patients require considerable time in the morning to clear secretions which are accumulated during sleep. They also benefit from the help of the physiotherapist. Procedures are therefore best delayed until midmorning so that clearance of secretions is completed prior to anaesthesia 2 !. Elective procedures should be done early in the week so that full medical and physiotherapy staff are available for the first few postoperative days when the greatest level of attention is required.
Premedication
As these patients need to actively clear secretions until coming to the operating room and need to resume this activity as soon as possible postoperatively, heavy sedative premedication is contraindicated. Some patients with poor peripheral venous access may benefit from an anxiolytic. Most patients require only reassurance and explanation. Bronchodilators and antibiotics should be continued. Perioperative insulin is rarely required except when high-dose steroids are used for immunosuppression of transplant patients. Analgesics may be appropriate when the surgical condition is associated with pain which limits active physiotherapy but otherwise opioid analgesics are best avoided.
Avoidance of postoperative constipation is a major consideration and a further reason to avoid the need for opioid analgesia. This is a serious complication as abdominal distension may severely compromise respiratory function. Prophylactic use of osmotically active laxatives will prevent constipation and obstruction in the postoperative period.
The incidence of gastroesophageal reflux is high. Use of H2 receptor antagonists and antacid premedication should be routine for these patients.
Monitoring
Pulse oximetry and blood gases should be checked with the patient breathing room air. This is important so that the level of oxygenation excepted in the postoperative period is realistic. Routine monitors should include ECG, oximetry and capnography. Invasive monitoring may be indicated according to the nature of surgery.
Induction
Intravenous induction is readily accepted provided that satisfactory venous access can be achieved. Preoxygenation to achieve a higher oxygen saturation prior to induction is particularly important, whether or not a rapid sequence induction is to be used. In our series, a range of intravenous induction agents were used. Propofol may be preferred because of the absence of histamine release and the recovery characteristics but should be used cautiously in small peripheral veins because of pain on injection.
On occasions when venous access was particularly difficult, inhalational induction with either halothane or enflurane was used. Although inhalational induction was slow because of the high functional residual capacity and the small minute volume, peripheral veins dilated during induction and allowed easy venepuncture for administration of other drugs. This was surprisingly well accepted by the patients and two patients have requested inhalation induction for subsequent anaesthetics.
In paediatric patients, atropine has been recommended to prevent bradycardia despite drying of secretions 2 ,4,21. The basis of this recommendation in CF is unclear. Bradycardia is less of a problem in adults. It may be that paediatric patients were less discriminating than adults, who sometimes complain of difficulty clearing dry secretions for days after atropine. In our opinion, there is no indication for routine use of atropine in adults and there are good reasons to avoid it.
Muscle Relaxants
The high frequency of reflux mandates use of suxamethonium in a significant proportion of CF patients. Muscle pains have a high incidence in this young group and may severely compromise postoperative physiotherapy. On occasions they have been so severe as to require use of opioid analgesics.
The ideal is complete spontaneous recovery at completion of surgery as full muscle power is required in the immediate postoperative period. Atracurium and vecuronium are the nondepolarizing drugs of choice because of their rapid clearance. Relaxants should be used in minimum doses according to clinical response: a nerve stimulator should be used to assess recovery. As soon as 75% train-of-four ratio is achieved, ventilation should be discontinued and the patient extubated when awake because of the accumulation of secretions. This avoids the need for reversal and the drying action of atropine.
Airway Management
Although many of these patients have extremely limited respiratory function, and some are in respiratory failure, spontaneous ventilation has been used for a variety of procedures. The degree of respiratory impairment has not been regarded as an indication for assisted ventilation for two major reasons. First, the duration of many procedures has been short. Relaxants would have prolonged anaesthesia unless either suxamethonium was used (with the risk of muscle pains) or the relaxants were reversed (with the drying action on secretions). Second, the patients with severe disease are those in whom full muscle power is most critical for maintenance of spontaneous ventilation. The laryngeal mask airway (LMA) was used on nine occasions. It has been well tolerated in most patients but in one case laryngeal spasm occurred and there was difficulty maintaining depth of anaesthesia with a volatile agent. These patients are at risk of aspiration, gas trapping, pneumothorax and major airway obstruction from secretions. The anaesthetist must be vigilant to the wide range of problems and carefully assess the reason for changes in the capnograph or peak inspiratory pressure.
Humidification
Dry secretions postoperatively may result from inadequate humidification of inspired gases. Addition of a heat and moisture exchanger (HME) to the circuit will improve humidification but at the cost of adding circuit deadspace and work of breathing. Severely affected patients have an FEV I of less than 10 mllkg body weight and are in chronic respiratory failure. The added deadspace of a mask and an HME, in combination with volatile anaesthetic, may precipitate severe carbon dioxide retention. An alternative is use of an LMA with an HME. When an endotracheal tube is used either an HME or heated humidifier should be used. Most of the patients are below ideal body weight and, like paediatric patients, are vulnerable to heat loss. The ventilatory limitations increase the danger of the increase in metabolic rate if shivering occurs to restore body temperature. For major procedures a heated humidifier is recommended. Instillation of normal saline (10 ml aliquots) and frequent suctioning will aid sputum clearance during the course of anaesthesia. Fibreoptic bronchoscopy adds little in these patients as the suction channel becomes blocked with the viscous secretions and sputum covers the lens of the bronchoscope.
Postanaesthesia Care
Postanaesthesia care, particularly provlSlon of appropriate nursing and physiotherapy care and provision of optimal analgesia must be considered in planning the procedure.
One can debate the most appropriate ward for postanaesthesia care of these patients. An argument can be made for care in an intensive care unit or highdependency surgical ward because of the experience of staff in postoperative care. Surgical wards often have more experience with analgesic techniques. The alternative view is that these patients should be managed in their usual respiratory ward where the staff are familiar to them and respiratory care appropriate to the CF patient will be ensured.
Analgesia
Use of local and regional analgesia minimizes the requirement for opioids and sedatives and is beneficial to aggressive postoperative physiothrapy. For minor procedures, use of local wound infiltration with bupivacaine reduces the need for opioids either as an anaesthetic supplement or for postoperative analgesia.
Abdominal and other suitable major procedures may be done with epidural anaesthesia alone or as a supplement to general anaesthesia with or without relaxants. Following major procedures, postoperative epidural analgesia with a low concentration of bupivacaine has become almost routine for these patients at our institution.
CONCLUSION
CF is a multisystem disease and the best survival has been obtained with a team approach to management. Perioperative management of CF patients requires anaesthetists, surgeons and other procedural specialist to involve themselves as part of that team. The requirments for involvement are communication and willingness to co-operate with other members of the team. Only with this approach will patients receive the best care at the right time.
